Trial Library

What Trial Library does

Trial Library, Inc. is a San Francisco-based, venture-backed software company spun out of UCSF in 2022 by physician-founder Dr. Hala Borno. It operates an AI-native platform that integrates oncology clinical trials into routine community care by activating oncologists, identifying eligible patients at the point of care through EHR-integrated alerts with match-confidence scoring, and navigating patients through the trial lifecycle via a combination of conversational AI, internal referral optimization, and human "Ally Navigators" who address logistical barriers (transportation, language, scheduling, food). The platform serves three buyer cohorts: biopharma sponsors seeking faster, more representative enrollment; community oncology providers and health systems who gain pre-screening reimbursement, trial search, and referral tooling at no cost; and payers and self-insured employers integrating trial access as a covered member benefit. Named partners and customers include Johnson & Johnson Innovative Medicine, Guardant Health, Texas Oncology, American Oncology Network, The Oncology Institute, Trinity Health, MemorialCare, and AccessHope, with the network reported at 840+ clinics and 3,000+ providers as of May 2026.

Name

Trial Library

Legal name

Trial Library, Inc.

Website

https://triallibrary.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

Trial Library is an AI-native platform that connects community oncology providers, biopharma sponsors, and payers to accelerate clinical trial enrollment and patient navigation, serving 840+ clinics and 3,000+ providers in the United States.

Ownership category

akta.pro rank

Product category

Clinical Trial Technology

NAICS

Other Scientific and Technical Consulting Services (541690), Computer Systems Design and Related Services (54151)

SIC

Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ), Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials) (HLAAANAI)

Keywords

• Clinical trial platform
• Patient trial matching
• Oncology clinical trials
• Clinical trial enrollment
• Healthcare AI software

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Biopharma Sponsor Services: Trial Library partners with biopharmaceutical companies (sponsors) to accelerate patient recruitment and enrollment for clinical trials. Sponsors pay for access to Trial Library's network of providers and pre-qualified patients, enabling faster enrollment and better representation in trials.
2. Payer & Employer Partnerships: Trial Library is the first platform to unlock the payer market for clinical trial access, aligning incentives across patients, providers, payers, and life-science partners. Revenue comes from integrating clinical trial access into member benefits for health plans and self-insured employers.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Trial Library operates an AI-native platform that integrates clinical trials into routine care by activating healthcare providers, identifying eligible patients through conversational search and EHR-integrated alerts, and navigating patients through the trial lifecycle. The platform connects biopharma sponsors, community oncology providers, and payers/employers into a coordinated research ecosystem, providing pre-screening services, intelligent navigation, and a rapidly growing network of 840+ clinics and 3,000+ providers.

Product overview

Trial Library is an AI-native platform offering a unified portfolio of clinical trial access solutions. The core Trial Library Platform integrates provider activation, patient-trial matching, and longitudinal navigation. Supporting modules include Health Provider Activation (intelligent pre-screening and referrals), Internal Referral Optimization (site augmentation for population analysis), Intelligent Navigation OS (AI-powered barrier resolution), and Conversational Trial Search (plain-language trial querying). The company also offers dedicated solutions for sponsors (provider/patient access), providers (rapid referral in under a minute), and payers/employers (benefit integration). Services include the Ally Navigation Program (human navigators addressing transportation, food, language, and scheduling barriers) and Clinical Trial Pre-screening Services (remote or in-person chart review by Clinical Data Coordinators). The platform currently operates across 840+ clinics and 3,000+ providers nationwide, serving biopharma sponsors, community oncologists, health plans, and self-insured employers.

Differentiator

Problem solved

Functional benefit

Products and services

• Trial Library Platform
• Conversational AI Trial Search
• For Sponsors
• For Providers
• For Payers & Employers
• Ally Navigation Program
• Clinical Trial Pre-screening Services

Quantifiable outcome

• 89% provider satisfaction rate with centralized trial search (published study)
• +3 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability6 records

Feature4 records

Partnerships

Six partnerships are on record, tiered core and strategic.

• Guardant HealthcoreTechnology or Integration · 11 December 2025Strategic collaboration announced December 2025 to increase access to cancer clinical trials across the United States. Combines Guardant's precision oncology diagnostics and genomic data (from over 1 million patients tested) with Trial Library's AI-powered patient matching and navigation platform. Partnership aims to address the gap between genomic discovery and clinical trial participation, particularly in rural communities.
• Johnson & Johnson Innovative MedicinecoreStrategic or Co-development Partner · 2 December 2025Leading global biopharmaceutical manufacturer partnering with Trial Library to accelerate R&D and patient enrollment. Partnership is part of Trial Library's growing ecosystem of pharma sponsors.
• The Oncology InstitutecoreStrategic or Co-development Partner · 2 December 2025Partnership with The Oncology Institute of Hope & Innovation to expand patient access to clinical trials. The Oncology Institute is part of Trial Library's rapidly expanding provider network.
• American Oncology NetworkcoreStrategic or Co-development Partner · 2 December 2025Strategic partnership with American Oncology Network (AON) to expand patient access to clinical trials across the network's oncology practices.
• Texas OncologycoreStrategic or Co-development Partner · 2 December 2025Partnership with Texas Oncology to expand patient access to clinical trials, providing pre-screening reimbursement and navigation support to the practice.
• AccessHopestrategicGTM or Marketing Partner · 15 October 2025AccessHope launched a new service utilizing technology from Trial Library to help more cancer patients enroll in clinical trials. Service targets community oncologists and aims to expand access to innovative treatments for socially vulnerable communities. Trial Library provides the technology foundation for patient-trial matching.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• TrialX: TrialX offers a patient-trial matching platform and clinical research exchange used by sponsors, providers, and patients. It targets the same clinical trial access problem with a similar multi-stakeholder approach, making it a comparable direct peer.
• H1: H1 provides a global platform connecting biopharma with clinical trial sites, investigators, and patient populations through data analytics. It overlaps with Trial Library's provider activation and site intelligence layer for biopharma sponsors.
• Deep 6 AI: Deep 6 AI uses AI to mine EHR data for patient-trial matching, focused on accelerating oncology and rare disease enrollment. It competes directly with Trial Library in AI-driven site activation and patient identification for community-based trials.
• Mendel: Mendel applies large language models to structured and unstructured clinical data for patient-trial matching. It targets similar biopharma sponsors and health systems for cohort identification, making it a closely overlapping competitor in clinical trial enablement.
• Massive Bio: Massive Bio operates an AI-enabled oncology clinical trial enrollment platform that connects patients and providers to trials, with a strong emphasis on community oncology and minority representation. It is one of Trial Library's closest direct competitors in oncology enrollment enablement.
• Verana Health: Verana Health turns specialty clinical data into real-world evidence and trial-ready cohorts. Trial Library's Chief Product Officer Karim Damji was a founding team member, indicating deep operational overlap in life-sciences data and clinical trial enablement.

Emerging players

• Science 37: Science 37 pioneered decentralized and hybrid clinical trial operations, with patient recruitment and remote participation capabilities. It is comparable on the decentralized/community trial thesis but operates with a fuller operational stack than Trial Library's tech-led model.
• Medable: Medable provides a decentralized clinical trial platform for eCOA, eConsent, and remote patient engagement. While its software targets trial sponsors and sites similarly, it focuses on enabling tech infrastructure rather than community oncology provider activation.

Broad incumbents

• Tempus AI: Tempus combines precision oncology diagnostics (similar to Trial Library's Guardant integration) with a clinical trial matching layer (TIME program). It serves overlapping biopharma sponsors and offers broader data, but is a much larger, broader platform rather than a focused community-trial network.
• Flatiron Health: Flatiron Health (acquired by Roche) offers oncology-specific EHR, real-world evidence, and clinical trial enablement. It serves biopharma sponsors with similar use cases but operates at much greater scale and as part of a wider oncology data portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/triallibrary

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds3 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trial Library